Sanofi Fails To Shake Eisai's Lovenox Antitrust Suit

Law360, New York (August 11, 2010, 3:23 PM EDT) -- Sanofi-Aventis US LLC has lost its bid to nix Eisai Inc.'s antitrust suit accusing the pharmaceutical giant of drafting sales contracts for the anti-coagulant drug Lovenox that allow it to maintain an illegal stronghold on the low-molecular-weight heparin market.

Judge Mary L. Cooper of the U.S. District Court for the District of New Jersey denied Sanofi's motion for summary judgment Tuesday, rejecting the argument that Eisai lacked standing to bring the suit because it is only the distributor of a competing anti-coagulant drug called Fragmin, which...
To view the full article, register now.